课题基金 / 基金详情

Georgia Clinical & Translational Science Alliance (GaCTSA)

Georgia Clinical & Translational Science Alliance (GaCTSA)
佐治亚临床
批准号:
10424822
负责人:
Andres J Garcia
金额:
$17.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-22 至 2022-08-30

项目摘要

项目成果

Andres J Garcia的其他基金

相似基金

相关文献

中文摘要
翻译
格鲁吉亚临床和转化科学联盟(GaCTSA)是一个引人注目的合作伙伴关系, 埃默里大学、莫尔豪斯医学院、格鲁吉亚理工学院和 格鲁吉亚,一个新的学术成员增加资源和资产,我们的CTSA。GaCTSA的另一个关键是我们的 医疗保健合作伙伴:埃默里医疗保健,莫尔豪斯医疗保健,亚特兰大儿童保健,亚特兰大 VA医疗中心,格雷迪卫生系统,亚特兰大社区医生网络和我们的 翻译科学合作伙伴,包括耶基斯国家灵长类动物研究中心(位于埃默里), 格鲁吉亚研究联盟,格鲁吉亚生物和链接到预防研究中心的美国中心, 疾病控制和预防(CDC)。在过去十年的合作中,GaCTSA的合作伙伴 已经建立了强大的研究网络,GaCTSA已经成为一个“24小时”的家和创新的催化剂, 高质量的临床和转化研究,具有地方,国家和全球影响力。UGA的加入 使GaCTSA能够更好地吸引我们州大量的农村和服务不足的人口,并增加了新的 资源,包括:在糖生物学,传染病,一个健康,一个杰出的转化研究 新的临床和转化研究单位,在教育,药学院优秀课程; 强有力的推广服务,超越其最初的农业使命,重点关注家庭健康; 拱门伙伴关系,其使命是连接格鲁吉亚社区与高等教育资源, 满足当地确定的关键社区需求。除了促进创新科学,GaCTSA将 鼓励合作,提高质量和效率,减少临床和转化研究的障碍 并加速将生物医学发现转化为临床应用的过程。关键点到下一个关键 资金周期,GaCTSA将强调创新的培训和劳动力发展,获得和 融合特殊人群和得不到充分服务的人群,加强生物医学信息学支持和能力, 提高质量和效率的新方法和流程,加强协作和参与, 以团队为基础,注重质量的预测科学。GaCTSA的具体目标反映了 NCATS咨询理事会工作组和2013年IOM审查CTSA的建议 程序. GaCTSA的具体目标将作为推动愿景和方法的指导原则。
英文摘要
The Georgia Clinical and Translational Science Alliance (GaCTSA) is a compelling partnership of Emory University, Morehouse School of Medicine, the Georgia Institute of Technology and the University of Georgia, a new academic member adding resources and assets to our CTSA. Also key to GaCTSA are our healthcare partners: Emory Healthcare, Morehouse Healthcare, Children’s Healthcare of Atlanta, the Atlanta VA Medical Center, the Grady Health System, and the Atlanta Community Physicians Network and our translational science partners including the Yerkes National Primate Research Center (located at Emory), the Georgia Research Alliance, Georgia Bio and links to the Prevention Research Centers of the US Centers for Disease Control and Prevention (CDC). Built over the past decade of collaboration, the partners of GaCTSA have forged strong research networks and GaCTSA has become a “24 hour” home and catalyst for innovative, high quality clinical and translational research with local, national and global impact. The addition of UGA allows the GaCTSA to better engage the large, rural and underserved populations of our state and adds new resources, including: outstanding translational research in glycobiology, infectious diseases, One Health, a new clinical and translational research unit, outstanding programs in Education, a School of Pharmacy; a robust extension service that reaches beyond its original agricultural mission to focus on family health; and the Archway Partnership whose mission is to connect Georgia communities with higher education resources to address critical, locally identified community needs. In addition to facilitating innovative science, GaCTSA will encourage collaboration, improve quality and efficiencies, reduce barriers to clinical and translational research and accelerate the process of translating biomedical discoveries into clinical applications. Key to the next funding cycle, GaCTSA will emphasize innovative training and workforce development, access to and integration of special and underserved populations, enhanced biomedical informatics support and capabilities, new methods and processes to improve quality and efficiency, enhanced collaboration and engagement and team-based, quality focused predictive science. The specific aims of GaCTSA reflect the vision and goals of NCATS Advisory Council Working Group and the recommendations of the 2013 IOM review of the CTSA program. The GaCTSA’s specific aims will serve as guiding principles to drive the vision and approach.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hydrogels for human beta cell survival, function and evasion of immune rejection
  • 批准号:
    10512947
  • 项目类别:
  • 资助金额:
    $82.23万
  • 财政年份:
    2022
  • 负责人:
    Andres J Garcia
  • 依托单位:
Hydrogels for human beta cell survival, function and evasion of immune rejection
  • 批准号:
    10705265
  • 项目类别:
  • 资助金额:
    $77.29万
  • 财政年份:
    2022
  • 负责人:
    Andres J Garcia
  • 依托单位:
Hydrogels for human beta cell survival, function and evasion of immune rejection
  • 批准号:
    10865870
  • 项目类别:
  • 资助金额:
    $8.27万
  • 财政年份:
    2022
  • 负责人:
    Andres J Garcia
  • 依托单位:
BIOMATERIALS FOR STEM CELL DERIVED BETA CELL TRANSPLANTATION
  • 批准号:
    10517827
  • 项目类别:
  • 资助金额:
    $1.98万
  • 财政年份:
    2021
  • 负责人:
    Andres J Garcia
  • 依托单位:
海外基金